News Search Results
Oct 06, 2025, 12:14 ET New Survey: Most Americans Believe Plasma Donation Saves Lives, Yet Few Have Donated
The Plasma Protein Therapeutics Association (PPTA) is a dynamic trade association that represents a unique sector of the biologics and biotechnology industry. PPTA represents more than 1,000 human plasma collection centers in North America and Europe, as well as the manufacturers of lifesaving
More news about: The Plasma Protein Therapeutics Association
Oct 06, 2025, 10:55 ET Dry Ice Making Equipment Market to Reach USD 800 Million by 2033 at a Robust CAGR of 6.5% from 2026-2033 - Market Research Intellect
3. Rising Adoption in the Pharmaceutical Sector The pharmaceutical and biotechnology industries are emerging as major consumers of dry ice, fueling equipment demand. With the global surge in temperature-sensitive vaccines, biologics,
More news about: Market Research Intellect
Oct 06, 2025, 10:30 ET 3D Cell Culture Market worth US$2.26 billion by 2030 with 11.7% CAGR | MarketsandMarkets™
By end users, the 3D cell culture market is segmented into pharmaceutical & biotechnology companies, research institutes, the cosmetics industry, and other end users. Pharmaceutical & biotechnology companies accounted for the largest share of the 3D cell culture market in 2024. Increase
More news about: MarketsandMarkets
Oct 06, 2025, 10:23 ET Made Scientific and Streamline Bio Announce Collaboration to Accelerate AI-Driven Robotic Manufacturing for Cell Therapies
spirit of a specialist CDMO with the global expertise and resources of GC Corporation of South Korea, a global leader in the pharmaceutical and biotechnology sectors. About Streamline Bio Streamline Bio is an AI-driven, autonomous
More news about: Made Scientific, Inc.
Oct 06, 2025, 10:20 ET By 2035, Advanced Wound Care Market Will Surpass USD 20.6 Billion at 7.7% CAGR Growth | Vantage Market Research
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Oct 06, 2025, 10:17 ET Pendulum Therapeutics Appoints Former Starbucks CEO Laxman Narasimhan to Board of Directors
Pendulum Therapeutics, the biotechnology company pioneering microbiome science to transform human health, today announced the appointment of Laxman Narasimhan, former Chief Executive
More news about: Pendulum Therapeutics
Oct 06, 2025, 09:00 ET NeuroSense: PrimeC Produces Statistically Significant Reductions in Alzheimer's Disease Biomarkers
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced new positive findings based on plasma samples from its
More news about: NeuroSense
Oct 06, 2025, 09:00 ET American Student Assistance Empowers High Schoolers to Award Nearly One Million Dollars in Funding to Massachusetts Nonprofits Through Innovative Youth-Led Grantmaking Pilot Program
themselves," said Dr. Natalie Kuldell, Executive Director of BioBuilder. "With ASA's support, we can help more students connect classroom learning to biotechnology careers, and the impact they can have on the world." Dylan Stark, a student participant in the
More news about: American Student Assistance (ASA)
Oct 06, 2025, 09:00 ET Leap Therapeutics Announces $58.88 Million Private Placement in Cash Commitments Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
CAMBRIDGE, Mass., Oct. 6, 2025 /PRNewswire/ -- Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced $58,888,888 in cash commitments for a private investment
More news about: Leap Therapeutics, Inc.
Oct 06, 2025, 08:30 ET Neuropsychiatry Clinical Trials: Evolving with Portable EEG and Digital Endpoints, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 06, 2025, 08:30 ET Patient Experience Organization Model for Clinical Trial Success, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 06, 2025, 08:30 ET Novel Long RNA Manufacturing Approaches for Advancing RNA Therapeutics, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 06, 2025, 08:00 ET Matica Biotechnology Emerges as the Go-To CDMO for Cell & Gene Therapy in 2025
continue advancing next-generation cell and gene therapies. About Matica Biotechnology, Inc. Matica Biotechnology is a viral vector Contract Development and Manufacturing Organization (CDMO) that leverages advanced technologies at
More news about: Matica Biotechnology, Inc.
Oct 06, 2025, 08:00 ET Lipidio Pharmaceuticals Expands Advisory Team with Appointment of Renowned Experts Arne Astrup, MD and Mark Lappe
cardiometabolic diseases. Mark Lappe Mark Lappe is an accomplished biotechnology executive with over thirty years of experience in executive management, investment, and leadership. He co-founded Inhibrx in 2010 and has served
More news about: Lipidio Pharmaceuticals, Inc.
Oct 06, 2025, 07:05 ET REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD
shown to lead to a decline in vision over time. ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered
More news about: REGENXBIO Inc.
Oct 06, 2025, 06:00 ET Oppenheimer Appoints James Yoo Managing Director in Healthcare Equity Capital Markets Investment Banking
Yoo has been named a Managing Director within its Healthcare Equity Capital Markets Investment Banking Group. In this role, Mr. Yoo will focus on Biotechnology Equity Capital Markets transactions. With 27 years of experience, Mr. Yoo has developed deep expertise in a range of financing
More news about: Oppenheimer & Co. Inc.
Oct 06, 2025, 02:11 ET FDA Lifts Clinical Hold on NUZ-001
Therapeutics Limited Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment
More news about: Neurizon Therapeutics Limited
Oct 06, 2025, 02:06 ET FDA Lifts Clinical Hold on NUZ-001
Therapeutics Limited Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment
More news about: Neurizon Therapeutics Limited
Oct 04, 2025, 10:30 ET Human Papilloma Virus/HPV Test and Pap Smear/Test Market worth US$3.94 billion by 2030 with 10.0% CAGR | MarketsandMarkets™
(India), Sacace Biotechnologies Srl (Italy), Jiangsu Mole Bioscience Co., Ltd. (China), HANGZHOU ALLTEST BIOTECH CO., LTD. (China), Hangzhou Tongzhou Biotechnology Co., Ltd. (China), and Nanjing Liming Biological Products Co., Ltd. (China). Hologic, Inc. (US):
More news about: MarketsandMarkets
Oct 03, 2025, 16:00 ET Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
LEXINGTON, Mass., Oct. 3, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that on October
More news about: Curis, Inc.
Oct 03, 2025, 11:09 ET Solarea Bio Appoints New Chief Executive Officer
Solarea Bio, a biotechnology company unlocking the plant-based microbiome to deliver science-backed solutions for healthy living, today announced the appointment of Catherine
More news about: Solarea Bio
Oct 03, 2025, 10:00 ET HanchorBio Announces Acceptance of HCB301 Abstract for Poster Presentation at SITC 2025 Annual Meeting
Oct. 3, 2025 /PRNewswire/ -- HanchorBio, a clinical-stage biotechnology company focusing on immune-oncology and dedicated to developing next-generation multi-specific immunotherapies, today announced that an abstract
More news about: HanchorBio Inc.
Oct 03, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
[Click here for information about joining the class action] Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. The Company is developing, among other
More news about: Pomerantz LLP
Oct 03, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPR
here for information about joining the class action] Jasper, a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria ("CSU"), Chronic Inducible
More news about: Pomerantz LLP
Oct 03, 2025, 08:05 ET Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
About Rigel Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders
More news about: Rigel Pharmaceuticals, Inc.